These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 12898310)

  • 1. Recognition by cellular and humoral autologous immunity in a human osteosarcoma cell line.
    Nabeta Y; Kawaguchi S; Sahara H; Ikeda H; Hirohashi Y; Goroku T; Sato Y; Tsukahara T; Torigoe T; Wada T; Kaya M; Hiraga H; Isu K; Yamawaki S; Ishii S; Yamashita T; Sato N
    J Orthop Sci; 2003; 8(4):554-9. PubMed ID: 12898310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of human autologous cytotoxic T-lymphocyte-defined osteosarcoma gene that encodes a transcriptional regulator, papillomavirus binding factor.
    Tsukahara T; Nabeta Y; Kawaguchi S; Ikeda H; Sato Y; Shimozawa K; Ida K; Asanuma H; Hirohashi Y; Torigoe T; Hiraga H; Nagoya S; Wada T; Yamashita T; Sato N
    Cancer Res; 2004 Aug; 64(15):5442-8. PubMed ID: 15289353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-associated-antigens or osteosarcoma cell line lysates: two efficient methods for in vitro generation of CTLs with special regard to MHC-I restriction.
    Muraro M; Mereuta OM; Saglio F; Carraro F; Cravero C; Fagioli F
    Cell Immunol; 2011; 266(2):123-9. PubMed ID: 21040906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of selected parameters of cellular immunity in children with osteosarcoma at diagnosis].
    Markiewicz K; Zeman K; Kozar A; Gołębiowska-Wawrzyniak M; Woźniak W
    Med Wieku Rozwoj; 2012; 16(3):212-21. PubMed ID: 23378399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human tumor-associated antigens detected by serological techniques: analysis of autologous humoral immune responses to primary and metastatic human sarcomas by an enzyme-linked immunoabsorbent solid-phase assay (ELISA).
    Roth JA; Wesley RA
    Cancer Res; 1982 Oct; 42(10):3978-86. PubMed ID: 6955005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of human autologous melanoma-specific cytotoxic T-cells using HLA-A2-matched allogeneic melanomas.
    Crowley NJ; Slingluff CL; Darrow TL; Seigler HF
    Cancer Res; 1990 Feb; 50(3):492-8. PubMed ID: 2404572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular immune response to human sarcomas: cytotoxic T cell clones reactive with autologous sarcomas. I. Development, phenotype, and specificity.
    Slovin SF; Lackman RD; Ferrone S; Kiely PE; Mastrangelo MJ
    J Immunol; 1986 Nov; 137(9):3042-8. PubMed ID: 3093588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological identification and bioinformatics analysis of immunogenic antigens in osteosarcoma.
    Liao B; Ma B; Liu Z; Zhang H; Long H; Yang T; Fan Q
    Cancer Biol Ther; 2007 Nov; 6(11):1805-9. PubMed ID: 18032929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of virus-induced rat osteosarcoma.
    Urovitz EP; Czitrom AA; Langer F; Gross AE; Pritzker PH
    J Bone Joint Surg Am; 1976 Apr; 58(3):308-11. PubMed ID: 1063128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal diversity of cytotoxic T lymphocytes that recognize autologous oral squamous cell carcinoma.
    Kobayashi J; Hirohashi Y; Torigoe T; Michifuri Y; Yamamoto T; Tamura Y; Kamiguchi K; Miyazaki A; Yamaguchi A; Hariu H; Hiratsuka H; Sato N
    Hum Immunol; 2009 Feb; 70(2):89-95. PubMed ID: 19124056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous CTL response against cancer stem-like cells/cancer-initiating cells of bone malignant fibrous histiocytoma.
    Kano M; Tsukahara T; Emori M; Murase M; Torigoe T; Kawaguchi S; Wada T; Yamashita T; Sato N
    Cancer Sci; 2011 Aug; 102(8):1443-7. PubMed ID: 21518139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The host immune response in human osteosarcoma.
    McMaster JH; Ferguson RJ; Weinert CR
    Clin Orthop Relat Res; 1975 Sep; (111):76-82. PubMed ID: 1057466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE; Spits H
    J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of antitumor immunity by combining anti-cytotoxic T lymphocyte antigen-4 antibodies and cryotreated tumor lysate-pulsed dendritic cells in murine osteosarcoma.
    Kawano M; Itonaga I; Iwasaki T; Tsumura H
    Oncol Rep; 2013 Mar; 29(3):1001-6. PubMed ID: 23291864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Auto T cells expressing chimeric antigen receptor derived from auto antibody might be a new treatment for osteosarcoma.
    Weibo P; Zhaoming Y
    Med Hypotheses; 2012 May; 78(5):616-8. PubMed ID: 22330890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic phenotype and phagocytic capacity of MG-63 osteosarcoma line.
    Díaz-Rodríguez L; García-Martínez O; Arroyo-Morales M; Reyes-Botella C; Ruiz C
    Ann N Y Acad Sci; 2009 Sep; 1173 Suppl 1():E46-54. PubMed ID: 19751414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated in vivo B7-1 gene transfer induces anti-tumor immunity against pre-established primary tumor and pulmonary metastasis of rat osteosarcoma.
    Tsuji H; Kawaguchi S; Wada T; Nagoya S; Inobe M; Yamashita T; Ishii S; Uede T
    Cancer Gene Ther; 2002 Sep; 9(9):747-55. PubMed ID: 12189524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A parathyroid-hormone-related-protein (PTH-rP)-specific cytotoxic T cell response induced by in vitro stimulation of tumour-infiltrating lymphocytes derived from prostate cancer metastases, with epitope peptide-loaded autologous dendritic cells and low-dose IL-2.
    Correale P; Micheli L; Vecchio MT; Sabatino M; Petrioli R; Pozzessere D; Marsili S; Giorgi G; Lozzi L; Neri P; Francini G
    Br J Cancer; 2001 Nov; 85(11):1722-30. PubMed ID: 11742494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy of osteosarcoma patients with virus-modified tumor cells.
    Green AA; Pratt C; Webster RG; Smith K
    Ann N Y Acad Sci; 1976; 277(00):396-411. PubMed ID: 1069558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pluripotent stem cell-derived CTLs targeting FGFR3-TACC3 fusion gene in osteosarcoma.
    Zhan H; Xiao J; Shi S; Zou F; Wang S; Mo F; Liu X; Zhang B; Dai M; Zeng J; Liu H
    Int Immunopharmacol; 2024 Dec; 142(Pt B):112862. PubMed ID: 39306889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.